• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

arzerra (ofatumumab) - Articles and news items


FDA approves Genmab’s ofatumumab for relapsed CLL

Industry news / 31 August 2016 / Niamh Louise Marriott, Digital Content Producer

Approval is supported by the Phase III complement study that evaluated ofatumumab in combination with FC versus FC alone in patients with relapsed CLL…


Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +